Assisted Reproductive Technology (ART) News and Research

RSS

A group of technologies called assisted reproductive technology (ART) that involves achieving conception with artificial assistance

Irvine Scientific's Vit Kit- Freeze, Vit Kit- Thaw and Oil for Embryo Culture receive CE mark approval

Irvine Scientific, a leader in Assisted Reproductive Technology (ART), announced today it received CE mark approval for its Vit Kit®- Freeze, Vit Kit®- Thaw and Oil for Embryo Culture. This news accompanies the recent announcement of CE mark approval for a number of other media for ART from Irvine Scientific.

30 Mar 2010

Cook Medical's new IVF culture-oil purification process reduces contaminant trace to below detectable limits

A new purification process developed by Cook Medical for culture oil used in assisted reproduction eliminates traces of contaminants below detectable limits of 0.1 parts per million. The oil is purified by a proprietary refining technique that removes hydrocarbon impurities, which can have adverse effects on fertilization and threaten the viability of the developing embryos. The culture oil viscosity, MEA and LAL parameters remain unchanged.

27 Mar 2010

FDA approves Irvine Scientific's Vit Kit-Freeze and Vit Kit-Thaw for cryopreservation of all stages of embryos

Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced today that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area.

16 Mar 2010

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.

4 Mar 2010

Getting pregnant the "traditional" way or by assisted reproduction does not affect birthing process or the baby

Whether a women gets pregnant the "traditional" way or by assisted reproduction has no effect on the birthing process itself or the baby, researchers at the Norwegian University of Science and Technology (NTNU) have found.

2 Mar 2010

Women who become pregnant with single foetus after IVF/ICSI have increased risk of stillbirth

Women who become pregnant with a single foetus after in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) have an increased risk of a stillbirth, according to new research out today (Wednesday).

24 Feb 2010

Children born through assisted reproduction at greater risk of obesity and type 2 diabetes related defects

More than three million children have been born as a result of assisted reproductive technologies since the birth of the first "test tube baby" in 1978. While the majority of these children are healthy and normal, as a group they are at greater risk of certain kinds of birth defects and being low birth weight, which is associated with obesity, hypertension and type 2 diabetes later in life.

22 Feb 2010

Infertility patients from across GTA demand government-funded IVF

Infertility patients from across the GTA gathered at Queen's Park this morning to demand government-funded in vitro fertilization (IVF). Larger than life children's building blocks on the steps of the provincial legislative building spelled out the $550 million the Ontario Expert Panel on Infertility and Adoption says the province could save in long term health care and social services costs by funding IVF.

16 Feb 2010

Merck receives marketing authorization for ELONVA

Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

28 Jan 2010

New Life Agency announces creation of nation's first IVF insurance program

New Life Agency, Inc. today announced that it has joined forces with New Jersey-based The Diamond Institute IVF Center and Walgreens Specialty Pharmacy to create the nation's first IVF insurance program. The Assisted Reproduction Care (ARC) Insurance Program(SM) offers patients suffering from infertility feasible financial solutions for the ever-rising costs of In Vitro Fertilization (IVF) treatments, procedures and fertility medications.

20 Jan 2010

Impact of life style factors on natural and medically assisted reproduction

The European Society of Human Reproduction and Embryology (ESHRE) has published a position statement on the impact of the life style factors obesity, smoking and alcohol consumption on natural and medically assisted reproduction.

20 Jan 2010

Symposium to discuss strategies for prevention and treatment of infertility announced

ESHRE invites you to attend its campus symposium on 'Prevention and treatment of infertility in modern society'.

19 Jan 2010

Effects of obesity, smoking and drinking on natural and medically assisted reproduction

19 Jan 2010

Bone marrow transplantation survivors can father children: new study says

Men who were previously deemed sterile due to aggressive cancer treatments may still be able to biologically father children according to a new study published in the journal, Bone Marrow Transplantation.

18 Jan 2010

Embryo biopsy safe for singleton pregnancies

The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.

23 Dec 2009

Embryo biopsy does not adversely affect health of newborn singleton PGD/PGS children

21 Dec 2009

Pure populations of immature cells that enable male reproduction isolated and transplanted

Reproductive researchers from the University of Pennsylvania and The Children's Hospital of Philadelphia have succeeded in isolating and transplanting pure populations of the immature cells that enable male reproduction in two species-human spermatogonia and mouse gonocytes. These germline stem cells, taken from testis biopsies, demonstrated viability following transplantation to mouse testes within a controlled laboratory setting.

15 Dec 2009

AFA to host a webinar on Catholics and IVF

On Monday, The American Fertility Association will host a webinar entitled Catholics and IVF: A Pastoral Approach, presented by Father Jon Pedigo. IVF, or In Vitro Fertilization, is a form of assisted reproductive technology (ART) often used by couples and individuals who are having difficulty conceiving a child naturally. During the IVF process, one or more embryos are implanted into a woman's uterus and the remaining, unused embryos are destroyed, frozen, or donated.

2 Dec 2009

EMEA's CHMP recommends approval of Merck's ELONVA

Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

20 Nov 2009

Northeast Assisted Fertility Group opens new office in Atlanta

The Northeast Assisted Fertility Group (NAFG), already the leading surrogacy and egg donation program in Boston and New York, is pleased to announce the opening of a new office that will expand its services and resources to all its clients in the Atlanta area.

19 Nov 2009